13F HOLDINGS REPORT
Aisling Capital Management LP
Quarter ended Q1 2025 · Filed May 13, 2025 · Accession 0001766721-25-000003
Total Value
$288.5M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | BBIO | 6,068,125 | $209.8M | 72.72% |
| 2 | Verona Pharma plc (VRNA) | 925050106 | 615,352 | $39.1M | 13.54% |
| 3 | Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | 1,025,000 | $12.6M | 4.36% |
| 4 | Bicara Therapeutics Inc. (BCAX) | BCAX | 568,919 | $7.4M | 2.57% |
| 5 | Monte Rosa Therapeutics Inc (GLUE) | GLUE | 1,472,331 | $6.8M | 2.37% |
| 6 | Nuvation Bio Inc. (NUVB) | NUVB | 2,541,009 | $4.5M | 1.55% |
| 7 | Compass Pathways Plc (CMPS) | CMPS | 1,198,418 | $3.4M | 1.19% |
| 8 | Biomea Fusion Inc (BMEA) | BMEA | 798,757 | $1.7M | 0.59% |
| 9 | CalciMedica, Inc. (CALC) | CALC | 521,114 | $995,328 | 0.35% |
| 10 | Elevation Oncology Inc (ELEV) | 28623U101 | 2,834,910 | $734,525 | 0.25% |
| 11 | Aclaris Therapeutics Inc (ACRS) | ACRS | 434,455 | $664,716 | 0.23% |
| 12 | Marker Therapeutics, Inc. (MRKR) | MRKR | 325,370 | $400,205 | 0.14% |
| 13 | OnKure Therapeutics, Inc. (OKUR) | OKUR | 88,607 | $381,010 | 0.13% |